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Abstract
Background: Double-stranded RNA dependent protein kinase (PKR) is a key regulator of the anti-viral innate immune
response in mammalian cells. PKR activity is regulated by a 58 kilo Dalton cellular inhibitor (P58
IPK), which is present in
inactive state as a complex with Hsp40 under normal conditions. In case of influenza A virus (IAV) infection, P58
IPK is known
to dissociate from Hsp40 and inhibit PKR activation. However the influenza virus component responsible for PKR inhibition
through P58
IPK activation was hitherto unknown.
Principal Findings: Human heat shock 40 protein (Hsp40) was identified as an interacting partner of Influenza A virus
nucleoprotein (IAV NP) using a yeast two-hybrid screen. This interaction was confirmed by co-immunoprecipitation studies
from mammalian cells transfected with IAV NP expressing plasmid. Further, the IAV NP-Hsp40 interaction was validated in
mammalian cells infected with various seasonal and pandemic strains of influenza viruses. Cellular localization studies
showed that NP and Hsp40 co-localize primarily in the nucleus. During IAV infection in mammalian cells, expression of NP
coincided with the dissociation of P58
IPK from Hsp40 and decrease PKR phosphorylation. We observed that, plasmid based
expression of NP in mammalian cells leads to decrease in PKR phosphorylation. Furthermore, inhibition of NP expression
during influenza virus replication led to PKR activation and concomitant increase in eIF2a phosphorylation. Inhibition of NP
expression also led to reduced IRF3 phosphorylation, enhanced IFN b production and concomitant reduction of virus
replication. Taken together our data suggest that NP is the viral factor responsible for P58
IPK activation and subsequent
inhibition of PKR-mediated host response during IAV infection.
Significance: Our findings demonstrate a novel role of IAV NP in inhibiting PKR-mediated anti-viral host response and help
us understand P58
IPK mediated inhibition of PKR activity during IAV infection.
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Introduction
Influenza A viruses (IAV) are negative sense segmented RNA
genome viruses [1,2] which can rapidly develop resistance to the
drugs available against them [3]. These viruses pose a continuing
threat of pandemics, thus it is imperative to develop novel strategies
to prevent their infection and spread [4]. Interactions between viral
proteins and host factors are often crucial for successful replication
of the virus in host cells [5]. Many of these interactions are aimed at
overcoming the early innate immune response of infected cells
against the virus [6]. Mammalian cells respond to viral infections
through several innate immune mechanisms [7]. One such crucial
antiviral mechanism is activation of PKR (a dsRNA dependent
protein kinase) which is phosphorylated upon encountering viral
dsRNA [8]. Activated PKR has several downstream substrates, one
of which is the eukaryotic translation initiation factor 2 alpha
subunit (eIF2a) [9–11]. Phosphorylation of eIF2a by activated PKR
renders it unable to participate in translation initiation leading to
translation arrest and inhibition of protein synthesis from viral
mRNAs [12,13]. Another effector function of PKR is activation of
transcription factor IRF3, which leads to the expression of IFN b
and inhibition of virus replication [14,15]. Being such a crucial
component of the host innate immune system, PKR is tightly
regulated by cellular inhibitors [16] and very often targeted by viral
proteins[17–20].For example,the non-structuralprotein1 (NS1)of
influenza virus directly binds to PKR and prevents its activation
[21,22]. Apart from PKR inhibition, NS1 is also involved in the
inhibition of other cellular signaling cascades, which lead to the
activation of anti-viral interferon response [23,24]. PKR activity is
also inhibited by a cellular 58 kDa protein, P58
IPK, which promotes
influenza viral replication [25,26]. In naı ¨ve cells, P58
IPK exists in an
inactive state in a complex with heat shock protein 40 (Hsp40),
which becomes active upon release from this complex [27].
Influenza virus infection leads to the dissociation of P58
IPK from
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20215Hsp40 and suppression of the PKR response [28,29]. However,
neither the viral component nor the mechanism responsible for this
event is known to-date.
Segment 5 of the influenza virus genome encodes for 498 amino
acids Nucleoprotein (NP) whose primary function is viral genome
encapsidation [30]. Apart from that, NP is also known to interact
with several viral and host factors and play additional roles in the
viral life cycle [31–37]. We were interested in identifying new
cellular interactors of NP from a highly virulent A/H5N1 bird-flu
isolate {A/Hatay/2004(H5N1)}, which may facilitate viral
replication. For this a H5N1 NP was used as bait to search for
novel interactors in a yeast two-hybrid system based screen of
human lung cDNA library. In the screen, we identified that IAV
NP interacts with human chaperone heat shock protein 40 (Hsp40)
[38]. Considering the known role of Hsp40 in regulation of PKR
activity during influenza A virus infection [27], we explored the
possibility of NP playing a regulatory role in this process. We
observed that expression of IAV NP in mammalian cells lead to
reduced phosphorylation of PKR and its substrate eIF2a. We thus
hypothesize that influenza NP is the viral factor that facilitates the
inhibition of PKR activation by releasing P58
IPK from Hsp40-
P58
IPK complex. Consistent with this hypothesis, we observed that
during IAV infection, the association of NP with Hsp40 coincided
with the release of P58
IPK from Hsp40. Also, RNAi-mediated
inhibition of NP expression in IAV infected cells enhanced the
phosphorylation of PKR and its downstream substrate eIF2a.N P
inhibition also led to enhanced IRF3 phosphorylation and IFN b
production which may be mediated by PKR activation. Collec-
tively, these findings identify a novel role for influenza A virus NP
in blocking the PKR-dependent antiviral response in influenza A
virus infected cells.
Results
Identification of human Hsp40 as an interacting partner
of H5N1 IAV NP
A human lung cDNA library was screened using IAV NP as
bait, in GAL4 based Matchmaker yeast two-hybrid system
(Clontech). Yeast cells (AH-109) were co-transformed with bait
and prey plasmids, and selected for growth on selective L
-T
-H
-
plates supplemented with 50 mM aminotriazole. b-galactosidase
positive colonies were further analyzed (Fig. S1A). Plasmids from
positive colonies were isolated and subjected to DNA sequencing
followed by BLAST analysis to identify their cDNA insert.
The mammalian chaperone heat shock protein 40 (Hsp40/
DNAJB11) was thus identified as an interacting partner of NP.
The strength of the NP-Hsp40 interaction was determined using a
quantitative b-galactosidase assay, and was found to be compa-
rable to the positive control used in the assay (Fig. S1B, bars 6 and
7 respectively, p-value=0.0668).
Transiently expressed IAV NP interacts with Hsp40 in
mammalian cells
The NP-Hsp40 interaction in mammalian cells was ascertained
using co-transfection of plasmids coding H5N1 NP and Hsp40 in
the HEK293T cells. Transfected cells were metabolically labeled
with S
35, and co-immunoprecipitation was performed using the
lysates with either NP- or Hsp40- specific antibodies. These results
showed that NP co-precipitated with Hsp40 and vice-versa
(Fig. 1A, lane 2 and 4). These results were confirmed using
A549 lung epithelial cells, which were transfected with NP
expressing plasmid, followed by immunoprecipitation. It was
observed that ectopically expressed NP could immunoprecipitate
endogenous cellular Hsp40 and vice-versa (Fig. 1B, panel 1 and 2).
A direct interaction between NP-Hsp40 was further confirmed
using a co-immunoprecipitation assay in which
35S labeled NP
and Hsp40 proteins were expressed from plasmids using in-vitro
coupled transcription-translation rabbit reticulocyte lysate system
(TNT, Promega, Inc) (data not shown). Collectively, these results
showed that IAV NP directly interacts with Hsp40.
IAV NP interacts with Hsp40 in human lung epithelial
cells infected with different pandemic and seasonal
influenza A viruses
To validate the interaction between IAV-NP and Hsp40
in virus-infected cells, we investigated the kinetics of expression
of NP and Hsp40 in A549 cells. A549 cells were infected with a
Figure 1. Detection of IAV NP-Hsp40 interaction in mammalian cells tranfected with NP expressing plasmid by
co-immunoprecipitation. A. HEK293T cells were pcDNA3.1-NP and pcDNA3.1-Hsp40 plasmids alone or in combination, followed by metabolic
labeling with S
35. 48 hours post-transfection cells were harvested and IP was setup using anti-NP-specific antibody and anti-Hsp40-specific antibody
followed by autoradiography. Lanes 2 and 4 show co-IP of Hsp40 with NP and vice-versa. Lanes 1 and 3 show anti-NP and anti-Hsp40 antibodies were
not cross reacting with Hsp40 and NP, respectively. B. A549 cells were transfected with pcDNA3.1-NP plasmid or control pcDNA3.1 plasmid. Cells
were harvested 48 hours post-transfection and immunoprecipitation was setup using anti-Myc tag antibody and anti-Hsp40 antibody, followed by
western blotting. Lane 2 of panel 1 shows co-IP of NP with Hsp40 and lane 2 of panel 2 shows co-IP Hsp40 with NP. Lane 1 of panel 1 and 2
represents control samples transfected with empty vector. Panels 3 and 4 show expression levels of NP and Hsp40 in cell lysates.
doi:10.1371/journal.pone.0020215.g001
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influenza virus (PR8) at a multiplicity of infection (MOI) of 1.
Although NP expression was maximal at 24 h post-infection,
Hsp40 expression levels remained unchanged throughout the
course of infection (Fig. 2A). Therefore, in subsequent experi-
ments, A549 cells were infected with PR8 at an MOI of 1 for 24 h
and lysates were prepared. A co-immunoprecipitation assay was
performed using infected and control cell extracts. PR8 NP was
able to co-precipitate endogenous Hsp40 (Fig. 2B, panel 2).
Conversely, Hsp40 was able to co-precipitate NP (Fig. 2B, panel
1). The NP-Hsp40 interaction was also observed when A549 cells
were infected with influenza virus isolates belonging to various
subtypes (Table 1). Co-immunoprecipitation of proteins from
A549 cells infected with these select viral isolates showed that NP
co-precipitated with Hsp40 in all cases without exception (Fig. 2C,
panel 1). A phylogenetic analysis of influenza NP genes used in the
experiment was constructed using the Neighbor-Joining method,
nucleotide model Tamura-Nei, in MEGA version 4 (Fig. S2). The
diversity of changes in NP amino-acid sequences of the strains
used in this study are shown in Fig. S3. The NP genes of IAV used
in the study had amino-acid sequence divergence in the range of
1% to 10% from Hatay/H5N1/2004 isolate. These results clearly
indicated that the NP-Hsp40 interaction was conserved among
seasonal human, avian H5N1 and the 2009 H1N1 pandemic
influenza A viruses.
IAV NP and Hsp40 co-localize primarily in the nucleus of
mammalian cells
It is known that under stress conditions the expression level of
Hsp40 is enhanced and its cellular localization changes from
cytoplasmic to nuclear [38], however its distribution in influenza
virus infected cells was not studied. Thus we investigated the
cellular localization pattern of IAV NP in context to Hsp40 in
mammalian cells. We transfected A549 cells with IAV NP
expressing plasmid for 24 h, and an immunofluorescence staining
was performed with specific antibodies. Results showed that NP
and cellular Hsp40 colocalize primarily in the nucleus (Fig. 3A,
Lower right panel). Similar results were obtained with A549 cells
infected with PR8 virus. Confocal microscopy revealed that NP
and Hsp40 were present primarily in the nucleus. However there
was significant amount of NP present in the cytoplasm at 24 h
post-infection (Fig. 3C, Lower right panel). We also observed that
Figure 2. Confirmation of Hsp40 interaction with NP of various influenza A viruses by co-immunoprecipitation. A. A time course
expression analysis was done to check levels of Hsp40 and NP in A549 cells infected with PR8 IAV at 1 MOI. Panel 1 shows NP reached its maximum
levels at 12 hours post-infection. Panel 2 shows that Hsp40 levels remained unchanged through the course of infection. B. A549 cells were infected
with PR8 IAV at 1 MOI and harvested 24 hours post-infection. IP was setup using NP-specific antibody and Hsp40-specific antibody. Lane 2 of panel 1
shows co-IP of NP with Hsp40 and lane 2 of panel 2 shows co-IP Hsp40 with NP. Lanes 1 of panel 1 and 2 represents control uninfected samples.
Panels 3 and 4 show expression levels of NP and Hsp40 in cell lysates, as detected by western blotting. C. A549 cells were infected with different
influenza A virus isolates, as indicated at 1 MOI. Cells were harvested 24 hours post-infection and IP was setup using NP specific antibody, followed by
western blotting. Panel 1 shows co-IP of Hsp40 with NP, panels 2, 3 and 4 show levels of NP, Hsp40 and b-Actin in the cell lysates used for IP. Lane 1
of all panels show control uninfected samples.
doi:10.1371/journal.pone.0020215.g002
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Lane no. Strain used for infection Genbank ID
1 Control Sham treated _
2 Influenza A/ Wisconsin/ 67/2005 (H3N2) (Seasonal Flu) GenBank: EU097866.1
3 Influenza A/Solomon Islands/3/2006 (H1N1) (Seasonal Flu) NP Sequence unavailable
4 Influenza A/California/08/2009 (H1N1) (Pandemic Flu) GenBank:FJ984366.1
5 Influenza A/Vietnam/1203/04 (H5N1) NP Sequence unavailable
6 Influenza A/Hong Kong/482/97 (H5N1) NP Sequence unavailable
doi:10.1371/journal.pone.0020215.t001
Figure 3. Co-localization of IAV NP and Hsp40 in nucleus of mammalian cells. A and B. A549 cells were transfected with pcDNA3.1-NP or
control pcDNA3.1 plasmid for 24 hours, and cells were fixed and processed for immunostaining. NP was stained using anti-Myc tag specific
p r i m a r ya n t i b o d ya n dA l e x a 4 8 8c o n j u g a t e ds e c o n d a r ya n t i b o d y( G r e e n ) .H s p 4 0w a ss t a i n e du s i n gH s p 4 0s p e c i f i cp r i m a r ya n t i b o d ya n dA l e x a
594 conjugated secondary antibody (Red). Nuclei were stained with DAPI. A shows pcDNA3.1-NP transfected cells whereas B shows control
pcDNA3.1 transfected cells. Panels are labeled for their respective staining. Lower right panel shows nuclear colocalization of NP and Hsp40. C
and D. A549 cells were infected with PR8 influenza A virus at 1 MOI for 24 hours, and cells were fixed and processed for immunostaining. NP
was stained using anti-NP monoclonal primary antibody and Alexa488 conjugated secondary antibody (Green). Hsp40 was stained using Hsp40
specific primary antibody and Alexa 594 conjugated secondary antibody (Red). Nuclei were stained with DAPI. Panels are labeled for their
respective staining. C shows PR8 infected cells whereas D shows control uninfected cells. Lower right panel in C shows primarily nuclear
colocalization of NP and Hsp40.
doi:10.1371/journal.pone.0020215.g003
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compared to uninfected cells (Fig. 3 C and D, upper right panels).
NP expression and association with Hsp40 coincides with
Hsp40-P58
IPK dissociation and downregulation of PKR
and eIF2a phosphorylation
Hsp40 is known to negatively regulate eIF2a phosphorylation
through PKR (27). Therefore, we next assessed if changes in PKR
and eIF2a phosphorylation occurred during the course of IAV
infection of A549 cells. We found that the phosphorylation of both
PKR and eIF2a increased initially between 1–2 h post-infection
and subsequently declined between 4–8 h post-infection (Fig. 4A,
panel 1,3). However the total PKR and eIF2a levels remained
unchanged (Fig. 4A, panel 2,4). Interestingly, NP expression also
was detected around 4 h post-infection and increased up to 8 h
post-infection (Fig. 4A, panel 5) which coincided with a decline in
p-PKR and p-eIF2a levels.
During IAV infection P58
IPK activity was increased as it was
released from Hsp40 binding [27]. We hypothesized that NP
might disrupt the P58
IPK-Hsp40 complex too and liberate P58
IPK.
To investigate this possibility, we monitored changes in the cellular
levels of P58
IPK and NP associated with Hsp40 during IAV
infection. A549 cells were infected with the PR8 virus, harvested at
different time points after infection and immunoprecipitation was
conducted using equal amounts of total protein and anti-Hsp40
antibody. Western blot analysis revealed that between 4 and 8 h
post-infection, the levels of NP associated with Hsp40 continued to
rise (Fig. 4B, panel 1) with a concomitant decline in P58
IPK
associated with Hsp40 (Fig. 4B, panel 2). During this period, total
amounts of Hsp40 and P58
IPK remained constant (Fig. 4B, panel
5, 6). These results were consistent with the hypothesis of replace-
ment of P58
IPK from Hsp40, by NP. These findings indicate that
the dissociation of P58
IPK-Hsp40 complex occurs around 4 to 8 h
post-infection, and is associated with downregulation of eIF2a
phosphorylation. Taken together, these results suggest that during
IAV infection, NP induces the dissociation of the P58
IPK-Hsp40
complex leading to an inhibition of PKR activation and
downregulation of eIF2a phosphorylation.
IAV NP expression leads to an inhibition of PKR activity
and downregulation of eIF2a phosphorylation
During IAV infection, the NS1 protein inhibits PKR activation
by directly interacting with it, and thereby ensuring continued
viral mRNA translation [21,22]. Results from our study indicated
that NP may also play a role in inhibiting PKR activity by
intercepting this pathway at the level of Hsp40. To examine this
aspect, we performed a time course study in HEK293T cells
transfected with the plasmid expressing IAV H5N1 NP by
monitoring p-eIF2a and p-PKR levels. Western blot analysis of
transfected cell lysate showed downregulation of both PKR and
eIF2a phosphorylation, which began as early as 12 h and was
most prominent at 36 h post-transfection (Fig. S4 A, B). The 36 h
time-point was selected to confirm this action of NP, and Western
blot analysis results from 3 independent experiments showed
significant reduction in the levels of p-PKR (Fig. 5A, panel 2 and
Fig. 5B) and p-eIF2a (Fig. 5C, panel 2 and Fig. 5D). To confirm
the PKR inhibitory action of NP, we transfected HEK293T cells
with NP-GFP expressing plasmid and inhibited NP expression
using specific siRNA (Table 2) against it (Fig. S5A). Inhibition of
NP expression led to an increase in p-PKR and p-eIF2a levels as
compared to control NP-GFP transfected cells (Fig. S5B). These
results suggest that the expression of NP leads to inhibition of PKR
activity in a NS1 independent manner. This action of IAV NP is
likely to be mediated through its interaction with Hsp40.
Figure 4. NP expression in IAV infected cells coincides with p-PKR and p-eIF2a downregulation and P58
IPK-Hsp40 dissociation.
A. A549 cells were infected with PR8 IAV at 1 MOI and cells were harvested at indicated time points post-infection. Western blotting was done to
check the expression levels of PKR, p-PKR, eIF2a, p-eIF2a, NP and NS1. Panel 7 shows equal loading trough b-Actin control. This experiment was
repeated thrice with similar results. B. A549 cells were infected with PR8 IAV at 1 MOI and cells were harvested at indicated time points. Protein
concentration was measured by Bradford method and equal amount of protein sample from each time point was used to set up IP with anti-Hsp40
antibody. Panel 1 shows the amount of NP co-immunoprecipitated with Hsp40. Panel 2 shows amount of P58
IPK co-immunoprecipitated with Hsp40.
Panel 3 shows amount of Hsp40 immunoprecipitated at different time points. Lanes 4, 5, and 6 show the levels of NP, Hsp40 and P58
IPK respectively,
in cell lysates at the indicated time points as detected by western blotting using antibodies specific to NP, Hsp40 and P58
IPK. Panel 7 shows equal
loading trough b-Actin control.
doi:10.1371/journal.pone.0020215.g004
IAV NP Exploits Hsp40 to Inhibit PKR Activation
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e20215siRNA mediated inhibition of NP expression in IAV
infected cells, leads to the upregulation of PKR, eIF2a and
IRF3 phosphorylation
We suppressed NP expression PR8 IAV infected A549 cells,
using a pool of gene specific siRNAs (Table 2), and determined its
effect on PKR activity. Expression of NS1 was also blocked using
siRNA against NS1 alone and in combination with NP siRNA to
establish their exclusive and combined contribution to PKR-
inhibition. A549 cells were first transfected with the indicated
siRNAs, and 6 hours later were infected with PR8 influenza virus.
Infected cells were harvested 24 h post-infection and cell lysates
were subjected to western blot analysis. We observed that
inhibition of NP expression led to upregulation of PKR
phosphorylation, as compared to the control (Fig. 6A, panel 1,
Fig. 6B). Increased PKR activity resulted in enhanced phosphor-
ylation of eIF2a and IRF3 (Fig. 6A, panel 2, 4, Fig. 6C, D).
Inhibition of NS1 had a similar effect, whereas inhibition of both
NP and NS1 had a cumulative effect on upregulation of PKR,
eIF2a, and IRF3 phosphorylation (Fig. 6B, C, D).
Inhibition of NP expression during IAV infection leads to
enhanced IFNb production and reduced virus replication
PKR mediated activation of IRF3 should lead to an increased
IFN response. Previous results confirmed the involvement of NP in
the inhibition of PKR and IRF3. To check the further
downstream effect of NP, we suppressed the expression of NP
using siRNAs as mentioned earlier. 24 hours post-infection, the
cells were harvested and RNA was isolated to determine IFNb and
Figure 5. NP expression in mammalian cells leads to downreglation of PKR and eIF2a phosphorylation. HEK293T cells were transfected
with NP expressing plasmid (pcDNA3.1-NP) or control plasmid (pcDNA3.1). Cells were harvested at 36 hours post-transfection and cell lysates were
subjected to western blotting analysis. A. Lane 1 of panel 2 shows significant downregulation of pPKR levels in NP transfected cells. Panel 1 shows NP
expression level, whereas panel 3 shows equal loading trough b-Actin control. B. Figure shows graphical representation of relative pPKR levels as
measured by western blotting followed by densitometric measurement in 3 independent experiments. Error bars represent standard deviation.
C. Lane 1 of panel 2 shows significant downregulation of p-eIF2a levels in NP transfected cells. Panel 1 shows NP expression level, whereas panel 3
shows equal loading trough b-Actin control. D. Figure shows graphical representation of relative p-eIF2a levels as measured by western blotting
followed by densitometric measurement in 3 independent experiments. Error bars represent standard deviation.
doi:10.1371/journal.pone.0020215.g005
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The inhibition of NP expression led to increased IFNb production
as compared to control (Fig. 7A, bar 2, 3). Furthermore, the
inhibition of NS1 had greater impact on IFNb production as
compared to that of NP, and there was a synergistic effect when
both NS1 and NP were inhibited (Fig. 7A, bar 4, 5). Increased
IFNb production should lead to reduced virus replication and
reduced production of Influenza vRNA. To confirm this, influenza
vRNA levels in the above mentioned samples were measured by
real-time PCR. Inhibition of NP or NS1 led to reduced vRNA
production as compared to control (Fig. 7A, bar 2, 3, 4), and
inhibition of both NP and NS1 together had greater synergistic
effect (Fig. 7B, bar 5).
Discussion
Heat shock proteins are stress response factors which also
regulate several cellular processes [39]. The Hsp40 family
chaperones are known to play important roles in protein folding,
translocation, cell signaling and apoptosis [40–42]. Very often they
are targeted by viral components for successful virus replication.
For example, Hsp40 is known to interact with HIV type 2 Vpx
protein and facilitate nuclear import of the pre-integration
complex [43]. HIV type 1 Nef protein interacts with Hsp40 to
enhance viral gene expression [44]. Hsp40 is also known to
interact with the HBV core protein and affect viral turnover [45].
Heat shock proteins are known to affect the viral replication of
influenza viruses also. For example Hsp90 is known to interact
with influenza virus polymerase components and aid in viral RNA
synthesis [46]. Hsp70 is also known to be involved in the nuclear
export of the RNP complex and play a role in temperature
dependence of IAV replication [47,48]. Likewise, Hsp40 is also
known to regulate PKR signaling in influenza virus infected cells
[25]. Similarly, the IAV NP is also a multifunctional protein that
interacts with a wide variety of viral and cellular macromolecules,
including RNA, PB1 and PB2 subunits of the viral RNA-
dependent RNA polymerase and the viral matrix protein [30–
33]. It also binds to several host factors which include CRM1,
UAP56, Alpha-importin 1 and NF90 [33–37]. Through these
interactions, IAV-NP is known to encapsidate the viral genome,
regulate virus transcription and replication, contribute towards
pathogenicity of virus, and help in interspecies transmission of the
virus [30]. However, so far IAV NP is not reported to play any role
in modulating the host antiviral response.
A key component of mammalian antiviral response mechanism is
dsRNA dependent protein kinase PKR, which is activated by viral
dsRNA [8]. Upon activation, PKR gets dimerized and autopho-
sphorylated at multiple serine and threonine residues. Activated
PKR phosphorylates eukaryotic translation initiation factor eIF2a,
which in phosphorylated state cannot participate in mRNA
translation [12]. This is an important strategy of the host to arrest
translation of viral mRNAs thereby limiting viral replication [9,13].
Another crucial host pathway which is activated by PKR is IRF3-
mediated IFNb production.Activation of PKRis knownto enhance
IRF3 phosphorylation and nuclear movement where it drives
expression of Interferon b production and built up of antiviral host
response [14]. Similarly, PKR also has other substrates such as
MAPK and iKKß which upon phosphorylation trigger various
signaling pathways leading to apoptosis or interferon response
[10,11]. Being such a crucial molecule, PKR is very often the target
of viral factors [15–18]. In case of influenza virus infection, viral
NS1 protein is known to bind directly to PKR and inhibit its
activation [20,21]. NS1 also inhibits the function of retinoic acid
inducible gene-I(RIG-I), a cytosolicpathogen sensor involved inthe
antiviral response [49]. Apart from that, PKR activity is controlled
by another mechanism where P58
IPK, the cellular inhibitor of PKR
is activated in influenza virus infected cells [25,28]. Further, P58
IPK
itself is inhibited by Hsp40 and is present as P58
IPK-Hsp40 complex
under normal conditions. Howeveruponinfluenzavirusinfection, it
is released from the Hsp40 complex and inhibits PKR activation
[24]. In a recent report, it was shown that M2 protein of influenza A
virus stabilizes the P58
IPK-Hsp40 complex and activates PKR
phosphorylation, probably during later stage of infection [50].
However the mechanism of dissociation of Hsp40-P58
IPK complex
and concomitant PKR inhibition during influenza virus infection
remain unknown.
Here, we report that IAV NP interacts with the human
chaperone Hsp40 and employs this interaction to mitigate PKR-
mediated antiviral response of the host. NP-Hsp40 interaction
was identified through a yeast two-hybrid screen and confirmed
in a cell-free translation system, in transfected cells and in
influenza virus infected cells. The interaction was found to be
conserved across different influenza A viruses, ranging from
seasonal, avian H5N1 virus and the 2009 H1N1 pandemic virus
despite substantial amino acid differences that range from 0–5%
within a subtype/group and 6–10% between the subgroups
in NP amino-acid sequence. Our findings demonstrate that IAV
NP is the viral component that dissociates P58
IPK from the
P58
IPK-Hsp40 complex during influenza virus infection in
mammalian cells. It was observed that during the course of
influenza virus infection in lung epithelial cells, a gradual
increase in the association of NP with Hsp40 coincided with a
concomitant decrease in P58
IPK association with Hsp40.
Increased activity of P58
IPK,p r o m o t e db yN P ,s h o u l dl e a dt o
the inhibition of PKR activation and subsequent downstream
effects (Fig. 8). In accordance with the above hypothesis, we
observed that ectopic expression of IAV NP in mammalian cells
substantially reduced the phosphorylation levels of PKR and
eIF2a. Furthermore, siRNA-mediated inhibition of NP expres-
sion during influenza virus infection led to increased phosphor-
ylation of PKR and eIF2a, confirming the role of NP in the
negative regulation of PKR. Although eIF2a is phosphorylated
by other kinases also, namely, HRI, GCN2 and PERK which are
activated during stress condition, only PKR is known to be
targeted by viral inhibitors [12]. In line with this, NP and NS1
had similar effects on PKR mediated eIF2a phosphorylation;
however their synergistic effect was higher than their individual
effects (Fig. 6 B).
Table 2. Sequences of siRNAs used in the study.
NPsiRNA1 59AAGCAGGGUAGAUAAUCACUU39
59GUGAUUAUCUACCCUGCUUUU39
NPsiRNA2 59GCAGGGUAGAUAAUCACUCUU39
59GAGUGAUUAUCUACCCUGCUU39
NPsiRNA3 59UCACUCACUGAGUGACAUCUU39
59GAUGUCACUCAGUGAGUGAUU39
NS1siRNA1 59AAGCAGGGUGACAAAGACAUU39
59UGUCUUUGUCACCCUGCUUUU39
NS1siRNA2 59GCAGGGUGACAAAGACAUAUU39
59UAUGUCUUUGUCACCCUGCUU39
NS1siRNA3 59AGACAUAAUGGAUCCAAACUU39
59GUUUGGAUCCAUUAUGUCUUU39
NP-GFP siRNA 59GAGCAGAAAUCCAGGGAAUUU39
59AUUCCCUGGAUUUCUGCUCUU39
doi:10.1371/journal.pone.0020215.t002
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result in IRF3 phosphorylation and concomitant IFNb produc-
tion. However IRF3 is not a direct substrate of PKR and it can get
activated by the RIG I pathway, NFkB pathway and other
unknown mechanisms [14,15]. Influenza NS1 protein is known to
inhibit PKR, RIG I and NFkB pathways, thus it is expected to
have greater impact on IRF3 phosphorylation as compared to NP,
which may inhibit only PKR mediated IRF3 phosphorylation
[23,24]. In line with this, we observed that NP inhibition during
IAV infection led to enhanced IRF3 phosphorylation, IFNb
production and reduced viral replication; however inhibition of
NS1 had greater impact on these events. As expected the
synergistic effect of NP and NS1 inhibition on IRF3 activity was
higher than their individual effects. The effect of NP on IFNb
production is also reflected on virus replication as siRNA-mediated
inhibition of NP led to reduced vRNA production. This effect may
also be attributed to the essential requirement of NP for proper
functioning of influenza virus polymerase. However the inhibitory
action of NP on PKR-mediated host response may also contribute
to the reduced virus replication in case of siRNA-mediated
inhibition of NP.
Based on our findings, we proposed a model for PKR inhibition
by influenza virus nucleoprotein as shown in Fig. 7. According to
this model, IAV NP interacts with Hsp40 and facilitates the release
of P58
IPK from it, which in turn inhibits PKR activation (Fig. 8).
Reduced PKR activity, on one hand leads to reduced eIF2a
phosphorylation and ensures continued translation from viral
mRNAs and on the other hand leads to reduced IRF3 mediated
Figure 6. Inhibition of NP expression IAV infected cells upregulates phosphorylation of PKR, eIF2a and IRF3. A549 cells were treated
with siRNA against NP, NS1 or NP andNS1 or control siRNA for 6 hours. Cells were then infected with PR8 virus at an MOI of 1. Cells were harvested at
24 hours post-infection and equal amounts of protein from control and treated cell extracts were subjected to western blot analysis. A. Lane 1 of
panels 1, 2 and 4 show control levels of p-PKR, p-eIF2a and p-IRF3, and lane 2 shows the effect of control siRNA on the same. Lane 3 in panel 1, 2 and
4 shows levels of p-PKR, p-eIF2a and p-IRF3 levels in case of NP inhibition. Lane 4 shows effect of NS1 inhibition. Lane 5 shows a synergistic effect of
NP+NS1 silencing on p-PKR, p-eIF2a and p-IRF3 levels. Lanes 3 and 5 of panel 6 show the silencing efficacy of NP siRNA and lanes 4 and 5 of panel 7
shows the silencing efficacy of NS1 siRNA. Panel 8 shows equal loading through b-Actin control. B, C and D. Graphs shows relative p-PKR, p-eIF2a and
p-IRF3 levels in virus infected cells pretreated with siRNAs, as measured by western blot followed by densitometric analysis of the protein bands. Plots
represent the mean and standard deviation of of three independent experiments.
doi:10.1371/journal.pone.0020215.g006
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already known to inhibit PKR activation and IRF3 phosphory-
lation [21,24], NP also participates in this process, but through a
different mechanism involving Hsp40. With structure information
of both NP and Hsp40 being available [30,42], it would be
interesting to see which domains and key amino-acid residues are
involved in this interaction. Since the NP-Hsp40 interaction is
conserved across influenza viruses of various subtypes including
the 2009 pandemic H1N1 virus, it serves as an important target
for developing anti-viral strategies.
Materials and Methods
Yeast Two-Hybrid Screening
GAL4 based Matchmaker (Clontech) yeast two-hybrid system
was used for screening human lung cDNA library, as described
previously [51]. H5N1 NP (A/Hatay/2004) gene cloned in pGBK
vector (Clontech) was used as bait and a mammalian cDNA
library cloned in pGAD (Clontech) vector was used as prey. The
AH109 strain of yeast was used for co-transformation of bait and
prey plasmids. The full-length Hsp40 gene was cloned into pGAD
vector and used in yeast two-hybrid assays. Colonies which grew
on L
-T
-H
- plates (Leucine, Tyrosine and Histidine dropout
standard dextrose media) supplemented with 50 mM Aminotria-
zole were considered positive. ß-Gal assays (liquid and filter) were
performed as per manufacturer’s protocols.
Cell culture and Plasmids
HEK 293T (human embryonic kidney) and A549 (adenocarci-
nomic human alveolar basal epithelial) cells were used for
transfection and infection experiments respectively. All cells were
grown in DMEM medium (Hyclone) supplemented with 10% FCS
(Hyclone), 100 units/ml Penicillin Streptomycin solution (Invitro-
gen). NP gene of A/ Hatay/ 2004 (H5N1) influenza virus was
cloned in pCDNA3.1 myc his vector (Invitrogen), pEGFPN1
vector (Clontech) and pGBKT7 vectors (Clontech) to generate
myc-tagged, GFP-tagged and GAL4 DNA BD fused NP,
respectively. Full-length human Hsp40 gene cloned in the
pCDNA3.1 myc his vector was kindly provided by M. D. Amaral
(Centri de Genetica Humana Instituto Nacional de Saude Dr.
Ricardo Jorge, Lisboa, Portugal).
Transfection and virus infection assays
All DNA transfections were done using Lipofectamine 2000
(Invitrogen) and cells were maintained in DMEM medium devoid of
serum and antibiotics. Six hours post-transfection, culture medium
was supplemented with 5% FCS and 24 h post-transfection the
medium was replaced with fresh culture medium. All virus infections
were done at multiplicity of infection (MOI) of 1 for 1 h in DMEM
medium supplemented with 2% BSA (GIBCO). After 1 h incuba-
tion, the cells were washed with DMEM once and then grown with
DMEM supplemented with 0.2% BSA and 1 mg/ml N-p-tosyl-1-
phenyl alanine chloromethyl ketone (TPCK) (Sigma Aldrich). The
virus strains used in infection experiments are listed in Table 1.
Western blotting and antibodies
Cellswere lysed usinga buffer (20 mMHEPES,pH 7.5,150 mM
NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100) supplement-
ed with protease-inhibitors (Roche Diagnostics) and the lysates were
subject to SDS PAGE. Anti-NP antibodies were obtained from
Abcam and the Immunology and Pathogenesis Branch, Influenza
Division, Centres for Disease Control and Prevention, Atlanta, GA,
USA. Antibodies against PKR, p-PKR, eIF2a,p - e I F 2 a,P 5 8
IPK and
Hsp40were obtained from CellSignaling. Anti-ß-actinantibodywas
purchased from Sigma-Aldrich. Anti-myc tag and anti-NS1
antibodies were purchased from Santa Cruz.
Immunoprecipitation assays
Cellular lysates were incubated with primary antibody overnight
followed by incubation with protein A Dyna beads (Invitrogen) for
2 hours. Beads were washed thrice and the IP products were
subjected to Western blotting. NP was immunoprecipitated using
Figure 7. Inhibition of NP expression in IAV infected cells leads to reduced IFNb production and virus replication. A549 cells were
treated with siRNA against NP, NS1 or NP and NS1 together or control siRNA for 6 hours. Cells were then infected with PR8 virus at an MOI of 1. Cells
were harvested at 24 hours post-infection, RNA was isolated, cDNA was synthesized and real-time PCR was set up using primer specific for IFNb and
influenza NP vRNA. mRNA levels were normalized against b actin, and the result from triplicate experiments were plotted with standard deviation.
A. Graph shows the effect of NP and/or NS1 inhibition on IFNb production. B. Graph shows the effect of NP and/or NS1 silencing on NP vRNA
production, which is a measure of virus replication.
doi:10.1371/journal.pone.0020215.g007
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Branch/IPB, CDC, Atlanta) in case of infection or anti-myc tag
antibody in case of transfection. Hsp40 was immunoprecipitated
using anti-Hsp40 monoclonal antibody (Cell Signaling).
Immunofluorescence microscopy
After infectionor transfection for 24 h, A549 cells were fixed with
2% paraformaldehyde for 30 min at room temperature. They were
permeabilized with 0.5% Triton X-100 for 5 min at room
temperature and blocked with PBS containing 2% bovine albumin.
Immunostaining was performed using rabbit anti-Hsp40 (Cell
Signaling) and mouse anti-NP (IPB, CDC, Atlanta) antibodies.
Unbound antibodies were washed away with PBS and cells were
incubated with Alexa488 tagged Goat anti-rabbit antibodies and
Alexa594 tagged Goat anti-mouse. Nuclei were stained with DAPI.
Photomicrographs were captured at 1006 magnification using a
Leica DM6000B confocal microscope. Images wereprocessed using
NIS Elements AR 3.0 software (Nikon).
RNAi
Control (non-targeting) and NP- and NS1- specific siRNAs of
PR8 were purchased from Dharmacon and the cells were
transfected using the Dharmafect 1 transfection reagent (Dhar-
macon). In each case, a pool of three specific siRNAs capable of
targeting different regions of NP or NS1 were used (Table 2). A549
cells at a density of 10
6/well of a 6-well plate were transfected with
90 nM of the indicated siRNA for 6 h prior to infection with A/
PR/8/34 at a MOI of 1. Lysates were prepared 24 h post-
infection and analyzed for the expression of NP, NS1 and other
cellular proteins by Western blotting.
RNA isolation, cDNA preparation and Real time PCR
Total RNA was isolated from cells using the RNAeasy kit
(Qiagen, Valencia, CA, USA) and real-time RT-PCR was
conducted using a Stratagene Q3005 PCR machine for expression
of IFNb, b-actin mRNA and NP vRNA. For each sample, 2 mgo f
RNA was reverse transcribed using Superscript II Reverse
Transcriptase (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s directions. Oligo dT primers were used for IFNb
and b-Actin cDNA synthesis. For NP vRNA, cDNA was
synthesized as described by Ge et al [52]. (Parallel reactions without
reverse transcriptase were included as negative controls. Reverse
transcription reactions (1/50
th of each reaction) were analyzed in
using syber green Q-PCR reagents (Stratagene, La Jolla, CA, USA).
Figure 8. Proposed model for inhibition of PKR mediated host response by influenza nucleoprotein. During influenza virus infection, NP
interacts with Hsp40, thereby displacing P58
IPK from the Hsp40-P58
IPK complex. As a result, there is an increased amount of free P58
IPK available in
the cell which prevents PKR activation. Downregulation in PKR activity ensures less eIF2a phosphorylation and continued translation from viral
mRNAs. On the other hand reduced PKR activity also leads to reduced IRF3 activation and subsequent IFNb production.
doi:10.1371/journal.pone.0020215.g008
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30 s, and extension at 72uC for 30 s for a total of 45 cycles. The
threshold cycle number for cDNA was normalized to that of b-actin
mRNA,andtheresultingvaluewasconvertedtoa linearscale.Data
from three independent experiments were taken account for
analysis. All data points fell into a normal distribution and there
were no outliers. Primer sets used for these studies are provided in
Table 3.
Supporting Information
Figure S1 Human heat shock protein 40 was found to
interact with Influenza A nucleoprotein in yeast two-
hybrid system. A. Yeast two-hybrid screen was performed to
find the host interacting partners for H5N1 IAV NP. Results with
one of the positive co-transformants (later found to be Hsp40 by
BLAST analysis) are shown. Ah109 yeast strain cotransformed
with NP-GBK bait plasmid and Hsp40-GAD prey plasmid grew in
minimal synthetic YPD media devoid of Leucine, Tryptophan and
Histidine amino-acids. Positive colonies grew on plates supple-
mented with up to 50 mM aminotriazole (AT). A filter b-gal assay
was performed to confirm the interaction. Blue colored colonies
indicate positive clones. B. NP-Hsp40 interaction was confirmed
by liquid ß-gal assay and was found to be statistically comparable
to the positive control used (p-value=0.0668). In the bar-graph,
bar 1 represents untransformed AH109 yeast cells; bars 2 and 3
represent control prey plasmids, bars 4 and 5 represent prey
plasmids expressing full-length Hsp40 and NP, respectively; bar 6
represents the co-transformation of Hsp40 and NP plasmids; bar 7
is a positive control (SARS Coronavirus NP both as bait and prey
self-associating to form oligomers) [53].
(TIF)
Figure S2 Phylogenetic analysis of NP sequence used in
the study. A phylogenetic tree was constructed using Neighbor-
Joining method, nucleotide model Tamura-Nei, in MEGA version
4 [54]. NP gene sequences from selected human seasonal, avian,
swine and 2009 pandemic influenza viral isolates were used. The
tree shows evolutionary distances between various strains of
influenza. The 2009 pandemic H1N1 NP belongs to the classical
swine lineage which had previous limited introductions into
humans and is more distantly related to the NP of seasonal or H5
influenza viruses. The H5N1 virus used in this study is shown in
red and other IAVs used in infection assays are boxed.
(TIF)
Figure S3 Amino acid sequence comparison of NP
sequence used in the study. The number and percent
difference in amino acids of the IAV subtypes used in the
infection assays including seasonal H1N1 and H3N2, avian H5N1
and 2009 H1N1 pandemic are compared to A/Puerto Rico/8/1934
(H1N1) virus. Analyses were conducted using the Dayhoff matrix
based method in MEGA4 [48].
(TIF)
Figure S4 NP expression leads to decreased PKR and
eIF2a phosphorylation. A and B. Time-course analysis of p-
PKR and p-eIF2a levels in NP expressing plasmid transfected cells.
HEK 293T cells were transfected with pcDNA3.1-NP plasmid and
harvested at different time points. Protein amount was estimated by
Bradford method and equal amounts of protein from different time
points was analyzed on SDS-PAGE and subjected to western blot
analysis. Panel 1 of A and B shows, downregulation of p-PKR and p-
eIF2a levels as early as 12 hours (lanes 3 and 4), and was most
apparent at 36 hours post-transfection (lanes 7 and 8).
(TIF)
Figure S5 Inhibition of NP expression leads to in-
creased PKR and eIF2a phosphorylation. A. The effect of
siRNA-mediated inhibition of NP expression on PKR and eIF2a
phosphorylation in NP-transfected HEK293 T cells was checked.
Upper panel shows that a 30 nM concentration of siRNA was
optimum for silencing. B. Lower panel shows that when NP
expression was silenced, the levels of p-PKR and p-eIF2a went up
(lanes 4 and 3) which were otherwise downregulated (lane 1). Lane
2 shows mock transfected cells.
(TIF)
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